Cohen Shannon Munro, Kataoka-Yahiro Merle
University of Hawaii at Manoa School of Nursing, 2528 McCarthy Mall, Webster Hall, Honolulu, HI 96822, USA.
Mil Med. 2010 Feb;175(2):122-6. doi: 10.7205/milmed-d-09-00062.
The objective of this study was to determine whether health care providers at the Department of Veterans Affairs Medical Center (VAMC) in Salem, Virginia were adherent to lipid-lowering medication guidelines over a 5-year period. Five hundred randomly chosen electronic medical records of veterans with diabetes, congestive heart failure, and/or coronary artery disease were examined for the use of HMG-CoA reductase inhibitors as part of a larger study on patient-provider adherence to cardiovascular risk-reduction guidelines. Study findings indicated that health care providers prescribed HMG-CoA reductase inhibitors to patients at high risk per evidence-based guidelines. Provider adherence to guidelines rose each year of the study, which coincided with the Department of Veterans Affairs Medical Center efforts to educate health care providers about the evidence-based guidelines, utilization of computer-generated reminders, open access appointment scheduling, and increased collaboration with patients.
本研究的目的是确定弗吉尼亚州塞勒姆退伍军人事务医疗中心（VAMC）的医疗服务提供者在5年期间是否遵循降脂药物治疗指南。作为一项关于患者与医疗服务提供者遵循心血管风险降低指南的更大规模研究的一部分，对500份随机选取的患有糖尿病、充血性心力衰竭和/或冠状动脉疾病的退伍军人电子病历进行了检查，以了解HMG-CoA还原酶抑制剂的使用情况。研究结果表明，医疗服务提供者根据循证指南为高危患者开具了HMG-CoA还原酶抑制剂。在研究的每一年，医疗服务提供者对指南的遵循情况都有所提高，这与退伍军人事务医疗中心为向医疗服务提供者宣传循证指南、利用计算机生成提醒、开放预约安排以及加强与患者的合作所做的努力相吻合。
